Evidence map›Paper›PMID 40095910›Full record

ArticleJournal of clinical medicine2025

Effectiveness of Etanercept Biosimilar Initiating for Etanercept-Naive Patients, Using Ultrasound, Clinical, and Biomarker Assessments in Outcomes of Real-World Therapy (ENPORT-NGSK Study): An Interventional, Multicenter, Open-Label, Single-Arm Clinical Trial.

Remi Sumiyoshi, Shin-Ya Kawashiri, Toshimasa Shimizu, Tomohiro Koga, Rieko Kiya, Shigeki Tashiro, Yurika Kawazoe, Shuntaro Sato, Yukitaka Ueki, Takahisa Suzuki and 5 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Remi SumiyoshiDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Shin-Ya KawashiriDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.ORCID 0000-0002-2606-995X
Toshimasa ShimizuDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Tomohiro KogaDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Rieko KiyaClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Shigeki TashiroClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Yurika KawazoeClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Shuntaro SatoClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Yukitaka UekiRheumatic Disease Center, Sasebo Chuo Hospital, Sasebo 857-1195, Japan.
Takahisa SuzukiDepartment of Rheumatology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki 852-8511, Japan.
Tamami YoshitamaYoshitama Clinic for Rheumatic Diseases, Kagoshima 899-5117, Japan.
Yoshifumi TadaDepartment of Rheumatology, Saga University Hospital, Saga 849-8501, Japan.ORCID 0000-0003-0742-831X
Naoki HosogayaClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-3229-2277
Hiroshi YamamotoClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Atsushi KawakamiDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.

Funding

AYUMI Pharmaceutical Corporation NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersbiosimilaretanerceptmusculoskeletal ultrasound (MSUS)rheumatoid arthritis (RA)

Identifiers

PMID40095910
PMCPMC11900585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.